Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-10-28
1996-07-30
Ramsur, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548429, A61K 3140, C07D48704
Patent
active
055412165
ABSTRACT:
There are described compounds of the formula ##STR1## where (a) X is O or S;
REFERENCES:
patent: 2909530 (1959-10-01), Rudner
patent: 3457268 (1969-07-01), Frey et al.
patent: 3547945 (1970-12-01), Frey et al.
patent: 3547947 (1970-12-01), Frey et al.
patent: 3551450 (1970-12-01), Frey et al.
patent: 4765985 (1988-08-01), Leeson
patent: 4791107 (1988-12-01), Hamer et al.
patent: 4831155 (1989-05-01), Brufani et al.
patent: 4900748 (1990-02-01), Brossi et al.
patent: 4978673 (1990-12-01), Meroni et al.
patent: 5081117 (1992-01-01), Glamkowski et al.
patent: 5171750 (1992-12-01), Brossi et al.
patent: 5206260 (1993-04-01), Hichens et al.
Salway, Researches on the Constitution of Physostigmine, J. Chem. Soc., 101:978-989 (1912).
Polonovski, Alkaloids of the calabar bean. V. Action of phenyl isocyanate. Phenylic homologs of eserine and geneserine. Chemical Abstracts, Organic Chemistry, 10:1329 (1916).
Julian and Pikl, Studies in the Indole Series. V. The Complete Synthesis of Physostigmine (Eserine) J. Amer. Chem. Soc., 57:755-757 (1935).
Sibl and Snieckus, The Directed Ortho Lithiation of O-Aryl Carbamates. An Anionic Equvalent of the Fries Rearrangement, J. Org. Chem., 48:1935-1937 (1983).
King and Robertson, Experiments on the Synthesis of Physostigmine (Eserine) Part XI. The Later Phases of the Synthetical Investigations, J. Chem. Soc. 755-759 (1935).
Schonenberger et al., Comparison of (-)--Eseroline with (+)--Eseroline and Dihydroseco Analogues in Antinociceptive Assays: Confirmation of Rubreserine Structure by X-ray Analysis, J. Med. Chem., 29:2268-2273 (1986).
Schonenberger et al., Preparation of Optically Active Secondary Amines by Thermal Decomposition of (Methylbenzyl) urea Analogs: Absolute Configuration of (+)--and (-)--Mecamylamine, Helv. Chim. Acta, 69:283-287 (1986).
Schonenberger et al., Fragmentation of Optically Active (l-Phenylethyl)--and (l-Naphthylethyl) ureas in Refluxing Alcohols: Easy Preparation of Optically Active Amines of High Optical Purity), Helv. Chim. Acta, 69:1486-97 (1986).
Brzostowska, et al., Phenylcarbamates of (-)--Eseroline, (-)--Nl-Noreseroline and (-) --Physovenol: Selective Inhibitors of Acetyl and, or Butyrylcholinesterase, Med. Chem. Res., 2:238-246 (1992).
Chiang Yulin
Glamkowski Edward J.
Hamer Richard L.
Helsley Grover C.
Hoechst-Roussel Pharmaceuticals Inc.
Ramsur Robert W.
LandOfFree
Memory enhancing and analgsic 1,2,3,3A,8,8A-Hexahydro--3A, 8(And does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Memory enhancing and analgsic 1,2,3,3A,8,8A-Hexahydro--3A, 8(And, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Memory enhancing and analgsic 1,2,3,3A,8,8A-Hexahydro--3A, 8(And will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1659029